Discover insights from industry experts
Explore our library of insightful thought leadership and relevant healthcare industry topics
Search results will be updated while typing.
Info Sheet
Incorporating sustainability into our clinical research operations: a spotlight on Leeds Drapers Yard, UK
26 November 2025
Case Study
Fueling early-stage biotech growth with adaptive, patient-inclusive FIH trials
26 November 2025
Case Study
Empowering biotech innovations: End-to-end solutions for your immunotherapy trials
26 November 2025
Case Study
Delivering rapid results as an early-phase CRO partner
26 November 2025
Case Study
Maximizing the output of Phase I to streamline clinical development
26 November 2025
Info Sheet
Optimizing Phase Ib with the right partner
26 November 2025
White Paper
Phase I trials in autoimmune diseases review
26 November 2025
White Paper
Short-run, small window drug manufacture at the clinical research unit (CRU).
26 November 2025
White Paper
A guide to successful planning and execution
26 November 2025
White Paper
Combined advanced therapy medicinal products: European regulatory requirements, pathways and processes
26 November 2025
White Paper
Key chemistry, manufacturing, and controls strategies for the development of cell and gene therapies
26 November 2025
White Paper
Regulatory strategy considerations for advanced therapies
26 November 2025
White Paper
Practical considerations for cell and gene therapy trials in neonates and young children living with rare diseases
26 November 2025
White Paper
Finding the optimal dose in Project Optimus: Understanding your oncology asset and defining your possibilities
26 November 2025
White Paper
The hidden crisis in early-phase cancer trials: A challenge to be bold, creative and fearless
26 November 2025
White Paper
Why the UK Is Now a Strategic Hub for Early Clinical Trials.
26 November 2025
Info Sheet
Strengthening our commitment to sustainability at the Leeds Drapers Yard Clinical Research Unit (CRU)
26 November 2025
Article